Epidemiological Analysis on Endometrial Cancer in Guangdong Province of China

Endometrial Cancer Clinical Trial

Official title:

Epidemiological Analysis on Endometrial Cancer.

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT01761409
• Other study ID #: EC-2000-2010
• Status: Active, not recruiting
• Phase: N/A
• First received: January 3, 2013
• Last updated: January 3, 2013
• Start date: January 2000

Study information

• Verified date: January 2013
• Source: Third Affiliated Hospital, Sun Yat-Sen University
• Contact: n/a
• Is FDA regulated: No
• Health authority: China: Ministry of Health
• Study type: Observational

Clinical Trial Summary

Endometrial cancer is one of the most common gynecological cancers, and the incidence increasing in the world. However, there isn't any large sample data of endometrial cancer reported in China. Thus Endometrial cancer project of Guangdong province conduct a large multicentre clinical investigation about endometrial cancer.

Description:

Endometrial cancer project of Guangdong province is mainly conducted by the Department of Gynecology of the Third Affiliated Hospital of Sun Yet-sen University, and other 62 major hospitals in Guangdong province participate in this project. In this large multicentre clinical investigation, the endometrial cancer database including more than 10,000 cases has been established. Further the investigators will demonstrate the epidemiological characteristics, etiology, risk factors, clinical treatment and prognosis of endometrial cancer.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 10000
• Est. primary completion date: January 2013
• Accepts healthy volunteers: No
• Gender: Female
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• patients who was diagnosed with endometrial carcinoma from 2000 to 2010 in Guangdong province of China;

• patients with intact clinical and pathological information

Exclusion Criteria:

• not included in the inclusion criteria

Study Design

Observational Model: Case-Only, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Endometrial Cancer
• Endometrial Neoplasms

Locations

Country	Name	City	State
China	Third Affiliated Hospital,Sun Yet-sen University	Guangzhou	Guangdong

Sponsors (11)

Lead Sponsor	Collaborator
Third Affiliated Hospital, Sun Yat-Sen University	First Affiliated Hospital, Sun Yat-Sen University, First People's Hospital of Foshan, First People's Hospital, Shunde China, Guangdong General Hospital, Guangzhou Panyu Central Hospital, Jiangmen Central Hospital, Meizhou People's Hospital, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Sun Yat-sen University, Yuebei People's Hospital

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	survival rate		five years	Yes